Real-world application of amikacin liposome inhalation in managing complex mycobacterium avium pulmonary conditions

被引：0
|
作者：
Yanagihara, Toyoshi [1 ]
Mori, Asami [2 ]
Ogata, Hiroaki [1 ]
Kadowaki, Masako [3 ]
Moriuchi, Yuki [1 ]
Ishimatsu, Akiko [1 ]
Otsuka, Junji [1 ]
Taguchi, Kazuhito [1 ]
Moriwaki, Atsushi [1 ]
Yoshida, Makoto [1 ]
机构：
[1] NHO Fukuoka Natl Hosp, Dept Resp Med, Fukuoka, Japan
[2] NHO Fukuoka Natl Hosp, Dept Pharm, Fukuoka, Japan
[3] NHO Fukuoka Natl Hosp, Dept Infect Dis, Fukuoka, Japan
来源：
RESPIROLOGY | 2024年 / 29卷
关键词：
D O I：
暂无
中图分类号：
R56 [呼吸系及胸部疾病];
学科分类号：
摘要：
AP15-006
引用
收藏
页码：223 / 223
页数：1
相关论文
共 50 条
  • [21] Laryngeal Injury Due to Amikacin Inhalation for Refractory Mycobacterium avium Complex Infection
    Axiotakis, Lucas G.
    Enver, Necati
    Keating, Claire L.
    Pitman, Michael J.
    CHEST, 2021, 159 (04) : E185 - E187
  • [22] INTRACELLULAR KILLING OF MYCOBACTERIUM-AVIUM COMPLEX BY RIFAPENTINE AND LIPOSOME-ENCAPSULATED AMIKACIN
    BERMUDEZ, LEM
    WU, M
    YOUNG, LS
    JOURNAL OF INFECTIOUS DISEASES, 1987, 156 (03): : 510 - 513
  • [23] Inhaled Amikacin For The Treatment Of Pulmonary Mycobacterium Avium Complex (mac) Infection
    Benwill, J. L.
    Philley, J. V.
    Taskar, V.
    Brown-Elliott, B. A.
    Griffith, D. E.
    Wallace, R. J.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2014, 189
  • [24] EXTENSION STUDY OF AMIKACIN LIPOSOME INHALATION SUSPENSION (ALIS) FOR TREATMENT-REFRACTORY LUNG DISEASE CAUSED BY MYCOBACTERIUM AVIUM COMPLEX (MAC)
    Winthrop, Kevin
    Eagle, Gina
    Morimoto, Kozo
    Castellotti, Paola Francesca
    O'Donnell, Anne
    Ruoss, Stephen
    Aksamit, Timothy
    Nezamis, James
    Griffith, David
    CHEST, 2018, 154 (04) : 182A - 183A
  • [25] In reply-Amikacin Liposome Inhalation Suspension as a Treatment Option for Refractory Nontuberculous Mycobacterial Lung Disease Caused by Mycobacterium avium Complex
    Shulha, Jennifer
    MAYO CLINIC PROCEEDINGS, 2020, 95 (01) : 202 - 202
  • [26] Diagnosis and Management of Drug-Induced Interstitial Lung Disease Associated with Amikacin Liposome Inhalation Suspension in Refractory Mycobacterium Avium Complex Pulmonary Disease: A Case Report
    Hashimoto, Kazuki
    Nii, Takuro
    Sumitani, Hitoshi
    Yokoyama, Masashi
    Miyamoto, Satoshi
    Mihashi, Yasuhiro
    Nagata, Yuka
    Matsuki, Takanori
    Tsujino, Kazuyuki
    Miki, Keisuke
    Kida, Hiroshi
    INFECTION AND DRUG RESISTANCE, 2023, 16 : 6629 - 6634
  • [27] Clinical study of 20 cases of refractory Mycobacterium avium complex pulmonary disease treated with amikacin liposomal inhalation suspension
    Kaneko, Taichi
    Hagiwara, Eri
    Okuda, Ryo
    Ogura, Takashi
    RESPIROLOGY, 2024, 29 : 48 - 49
  • [28] Amikacin Liposome Inhalation Suspension (ALIS) for Treatment-Refractory Mycobacterium Avium Complex (MAC) Lung Disease: Effect of Baseline Amikacin and Clarithromycin Susceptibility on Culture Conversion
    Winthrop, K. L.
    Flume, P. A.
    Thomson, R.
    Brown-Elliott, B. A.
    Wallace, R. J., Jr.
    Griffith, D. E.
    Pennings, L. J.
    Coulter, C.
    Syrmis, M.
    Pandey, S.
    Yuen, D.
    Mange, K.
    van Ingen, J.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2020, 201
  • [29] LIPOSOME-ENCAPSULATED-AMIKACIN THERAPY OF MYCOBACTERIUM-AVIUM COMPLEX INFECTION IN BEIGE MICE
    CYNAMON, MH
    SWENSON, CE
    PALMER, GS
    GINSBERG, RS
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1989, 33 (08) : 1179 - 1183
  • [30] Amikacin Liposome Inhalation Suspension for Mycobacterium avium Complex Lung Disease A 12-Month Open-Label Extension Clinical Trial
    Winthrop, Kevin L.
    Flume, Patrick A.
    Thomson, Rachel
    Mange, Kevin C.
    Yuen, Dayton W.
    Ciesielska, Monika
    Morimoto, Kozo
    Ruoss, Stephen J.
    Codecasa, Luigi R.
    Yim, Jae-Joon
    Marras, Theodore K.
    van Ingen, Jakko
    Wallace, Richard J., Jr.
    Brown-Elliott, Barbara A.
    Coulter, Chris
    Griffith, David E.
    ANNALS OF THE AMERICAN THORACIC SOCIETY, 2021, 18 (07) : 1147 - 1157
12345